What's New

Fixed various bugs and added several minor enhancements.

App Description

"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.

The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."

iPhone Screenshots

(click to enlarge)

POINT 1 Study Site screenshot 1 POINT 1 Study Site screenshot 2 POINT 1 Study Site screenshot 3 POINT 1 Study Site screenshot 4

iPad Screenshots

(click to enlarge)

POINT 1 Study Site screenshot 5 POINT 1 Study Site screenshot 6 POINT 1 Study Site screenshot 7 POINT 1 Study Site screenshot 8

App Changes

  • June 16, 2019 Initial release

Other Apps From Parallel 6, Inc.

ABASD Room Finds stay local. Payson Petroleum OfferHubb App Top Tech Awards 6 Appeal Miramar Touch The Pivot Study TAReSA's Care Circle TAReSA Clinical6 Mobile Sanofi ACT14132 Site App Sanofi ACT14132 Patient App My APPLES Study Paratek PTK0796-UUTI-17201 Strata Oncology eStudy Subject App mClinical CCA GepoER Meds e-Study Lite Otsuka 31-14-204 Telemedicine POINT 1 Study GepoER e-Study Traditional VIR Patient Mobile App RELIEF Study Participant Vedanta-VE800 CHIEF-HF Virtual Study Support Valneva Release MSS1 Release MSS3 KRYSTAL-7 Vaccitech Release SCIS1 MHP-OA Study Release MSS5 VLA1553-302 NATiV3 KRYSTAL-12 Release MSS2 Herald Study Triumph Study Vertex MAGNIFY